BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 23089394)

  • 1. Local complement-targeted intervention in periodontitis: proof-of-concept using a C5a receptor (CD88) antagonist.
    Abe T; Hosur KB; Hajishengallis E; Reis ES; Ricklin D; Lambris JD; Hajishengallis G
    J Immunol; 2012 Dec; 189(11):5442-8. PubMed ID: 23089394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss.
    Liang S; Krauss JL; Domon H; McIntosh ML; Hosur KB; Qu H; Li F; Tzekou A; Lambris JD; Hajishengallis G
    J Immunol; 2011 Jan; 186(2):869-77. PubMed ID: 21149611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porphyromonas gingivalis manipulates complement and TLR signaling to uncouple bacterial clearance from inflammation and promote dysbiosis.
    Maekawa T; Krauss JL; Abe T; Jotwani R; Triantafilou M; Triantafilou K; Hashim A; Hoch S; Curtis MA; Nussbaum G; Lambris JD; Hajishengallis G
    Cell Host Microbe; 2014 Jun; 15(6):768-78. PubMed ID: 24922578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis.
    Maekawa T; Abe T; Hajishengallis E; Hosur KB; DeAngelis RA; Ricklin D; Lambris JD; Hajishengallis G
    J Immunol; 2014 Jun; 192(12):6020-7. PubMed ID: 24808362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baicalin inhibits toll-like receptor 2/4 expression and downstream signaling in rat experimental periodontitis.
    Sun JY; Li DL; Dong Y; Zhu CH; Liu J; Li JD; Zhou T; Gou JZ; Li A; Zang WJ
    Int Immunopharmacol; 2016 Jul; 36():86-93. PubMed ID: 27107801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement Involvement in Periodontitis: Molecular Mechanisms and Rational Therapeutic Approaches.
    Hajishengallis G; Maekawa T; Abe T; Hajishengallis E; Lambris JD
    Adv Exp Med Biol; 2015; 865():57-74. PubMed ID: 26306443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement and periodontitis.
    Hajishengallis G
    Biochem Pharmacol; 2010 Dec; 80(12):1992-2001. PubMed ID: 20599785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement receptor 3 blockade promotes IL-12-mediated clearance of Porphyromonas gingivalis and negates its virulence in vivo.
    Hajishengallis G; Shakhatreh MA; Wang M; Liang S
    J Immunol; 2007 Aug; 179(4):2359-67. PubMed ID: 17675497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR2 promoter hypermethylation creates innate immune dysbiosis.
    Benakanakere M; Abdolhosseini M; Hosur K; Finoti LS; Kinane DF
    J Dent Res; 2015 Jan; 94(1):183-91. PubMed ID: 25389002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of TLR2 in early innate immune response to acute pulmonary infection with Porphyromonas gingivalis in mice.
    Hajishengallis G; Wang M; Bagby GJ; Nelson S
    J Immunol; 2008 Sep; 181(6):4141-9. PubMed ID: 18768871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR activation enhances C5a-induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5L2.
    Raby AC; Holst B; Davies J; Colmont C; Laumonnier Y; Coles B; Shah S; Hall J; Topley N; Köhl J; Morgan BP; Labéta MO
    Eur J Immunol; 2011 Sep; 41(9):2741-52. PubMed ID: 21630250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergence of the systemic immune response following oral infection with distinct strains of Porphyromonas gingivalis.
    Marchesan JT; Morelli T; Lundy SK; Jiao Y; Lim S; Inohara N; Nunez G; Fox DA; Giannobile WV
    Mol Oral Microbiol; 2012 Dec; 27(6):483-95. PubMed ID: 23134613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement.
    Hajishengallis G; Liang S; Payne MA; Hashim A; Jotwani R; Eskan MA; McIntosh ML; Alsam A; Kirkwood KL; Lambris JD; Darveau RP; Curtis MA
    Cell Host Microbe; 2011 Nov; 10(5):497-506. PubMed ID: 22036469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential use of gallium-doped phosphate-based glass material for periodontitis treatment.
    Sahdev R; Ansari TI; Higham SM; Valappil SP
    J Biomater Appl; 2015 Jul; 30(1):85-92. PubMed ID: 25681404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage of the human C5A receptor by proteinases derived from Porphyromonas gingivalis: cleavage of leukocyte C5a receptor.
    Jagels MA; Ember JA; Travis J; Potempa J; Pike R; Hugli TE
    Adv Exp Med Biol; 1996; 389():155-64. PubMed ID: 8861006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyromonas gingivalis-mediated shedding of extracellular matrix metalloproteinase inducer (EMMPRIN) by oral epithelial cells: a potential role in inflammatory periodontal disease.
    Feldman M; La VD; Lombardo Bedran TB; Palomari Spolidorio DM; Grenier D
    Microbes Infect; 2011 Dec; 13(14-15):1261-9. PubMed ID: 21835259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D reduces the inflammatory response by Porphyromonas gingivalis infection by modulating human β-defensin-3 in human gingival epithelium and periodontal ligament cells.
    De Filippis A; Fiorentino M; Guida L; Annunziata M; Nastri L; Rizzo A
    Int Immunopharmacol; 2017 Jun; 47():106-117. PubMed ID: 28384529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptors 2 and 5 in human gingival epithelial cells co-operate with T-cell cytokine interleukin-17.
    Beklen A; Sorsa T; Konttinen YT
    Oral Microbiol Immunol; 2009 Feb; 24(1):38-42. PubMed ID: 19121068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increases in IL-33 production by fimbriae and lipopeptide from Porphyromonas gingivalis in mouse bone marrow-derived dendritic cells via Toll-like receptor 2.
    Tada H; Suzuki R; Nemoto E; Shimauchi H; Matsushita K; Takada H
    Biomed Res; 2017; 38(3):189-195. PubMed ID: 28637954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human β-defensin 3 inhibits periodontitis development by suppressing inflammatory responses in macrophages.
    Cui D; Lyu J; Li H; Lei L; Bian T; Li L; Yan F
    Mol Immunol; 2017 Nov; 91():65-74. PubMed ID: 28886588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.